SC 13G Filing

Company

Xenon Pharmaceuticals Inc.

Filed

November 14, 2014

Accession Number

0000921895-14-002436

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →